Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | PEPD | P12955 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.36 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26305265 | 1.00 | MEN1 (0.39) | MEN1BLMKMT2APEPDALDH1A1 | |
| SCHEMBL27646480 | 1.00 | MEN1 (0.39) | MEN1BLMKMT2APEPDALDH1A1 | |
| SCHEMBL11119035 | 1.00 | MEN1 (0.39) | MEN1BLMKMT2APEPDALDH1A1 | |
| SCHEMBL20824845 | 1.00 | MEN1 (0.39) | MEN1BLMKMT2APEPDALDH1A1 | |
| SCHEMBL26305263 | 1.00 | MEN1 (0.39) | MEN1BLMKMT2APEPDALDH1A1 | |
| SCHEMBL7734513 | 0.95 | PEPD (0.42) | MEN1BLMKMT2APEPDALDH1A1 | |
| SCHEMBL195046 | 0.95 | PEPD (0.42) | MEN1BLMKMT2APEPDALDH1A1 | |
| SCHEMBL4766405 | 0.95 | PEPD (0.42) | MEN1BLMKMT2APEPDALDH1A1 | |
| SCHEMBL18532463 | 0.95 | PEPD (0.42) | MEN1BLMKMT2APEPDALDH1A1 | |
| SCHEMBL9419364 | 0.93 | MEN1 (0.42) | MEN1BLMKMT2APEPDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9981913-B2 | Liver X receptor (LXR) modulators | RALEXAR THERAPEUTICS, INC. (US) | 2018-05-29 | — | — | US | disclosed |